Antimicrobial Resistance — MCQs
The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
The mechanism of direct transfer of free DNA involves _____
The molecular basis of penicillin resistance in *S. pneumoniae* is:
The most common mechanism of resistance to drugs in Staphylococcus is
Drug of choice in methicillin-resistant Staphylococcus aureus is:
What is the mechanism of resistance in MRSA?
All of the following are true about methicillin resistance in MRSA, except:
Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
All are false about tigecycline, except:-
Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Question 1: The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
- A. Translation
- B. Mutation (Correct Answer)
- C. Conjugation
- D. Transduction
Explanation: ***Mutation*** - **Random genetic changes** in bacteria can alter drug targets or introduce drug-inactivating enzymes, leading to resistance. - **Spontaneous mutations** in the bacterial genome are the primary source of new resistance genes that did not previously exist in the bacterial population. - While mutations occur at low frequency, they are the fundamental mechanism by which novel resistance traits first arise. *Translation* - This is the process of synthesizing proteins from mRNA; it is a fundamental cellular process and not a cause of drug resistance. - Errors in translation are generally lethal to the cell and do not typically confer specific drug-resistant phenotypes. *Conjugation* - This is a mechanism for **horizontal gene transfer** where bacteria directly transfer genetic material, including resistance genes, via a pilus. - While conjugation is the **most important mechanism for spreading resistance** in clinical settings, it transfers pre-existing resistance genes rather than creating new ones. *Transduction* - This is another form of **horizontal gene transfer** involving bacteriophages (viruses) carrying bacterial genes, including resistance genes, between bacteria. - Similar to conjugation, transduction is a mechanism for the **transfer** of pre-existing resistance genes, not their original creation.
Question 2: The mechanism of direct transfer of free DNA involves _____
- A. Mutation
- B. Conjugation
- C. Transformation (Correct Answer)
- D. Transduction
Explanation: ***Transformation*** - **Transformation** is a process of horizontal gene transfer where bacteria take up **free DNA** from their environment. - This DNA can originate from dead bacterial cells and be integrated into the recipient bacterium's genome. *Mutation* - A **mutation** is a spontaneous change in the nucleotide sequence of an organism's genome. - It does not involve the transfer of DNA from one organism to another, but rather an alteration within an existing gene. *Conjugation* - **Conjugation** involves the direct transfer of genetic material between bacterial cells through physical contact via a **pilus**. - This mechanism typically transfers large pieces of DNA, often plasmids, not "free DNA" from the environment. *Transduction* - **Transduction** is the process by which DNA is transferred from one bacterium to another by a **bacteriophage** (a virus that infects bacteria). - This mechanism requires a viral vector to carry the genetic material, distinguishing it from the direct uptake of free DNA.
Question 3: The molecular basis of penicillin resistance in *S. pneumoniae* is:
- A. Alteration in cell membranes
- B. Alteration in the cell wall
- C. Alteration of penicillin-binding protein (Correct Answer)
- D. Production of beta-lactamase enzyme
Explanation: ***Alteration of penicillin-binding protein*** - The primary mechanism of **penicillin resistance in *Streptococcus pneumoniae*** involves modifications to its **penicillin-binding proteins (PBPs)**, which are the targets of penicillin. - These alterations reduce the affinity of PBPs for penicillin, allowing cell wall synthesis to continue even in the presence of the antibiotic. *Alteration in cell membranes* - Changes in cell membranes are not the primary mechanism of **penicillin resistance** in bacteria. - **Penicillins** primarily target the **bacterial cell wall**, not the cell membrane. *Alteration in the cell wall* - While penicillin resistance *involves* the cell wall, the direct "alteration in the cell wall" itself is not the molecular basis. - The key is the change in the **PBPs** located within or associated with the cell wall, not a general change in the cell wall structure. *Production of beta-lactamase enzyme* - **Beta-lactamase production** is a common mechanism of penicillin resistance in many bacteria (e.g., *Staphylococcus aureus*, *Haemophilus influenzae*), but it is **not the primary mechanism for penicillin resistance in *Streptococcus pneumoniae***. - *S. pneumoniae* primarily relies on **altered PBPs** to evade penicillin, rather than enzymatic degradation of the antibiotic.
Question 4: The most common mechanism of resistance to drugs in Staphylococcus is
- A. Transformation
- B. Transduction (Correct Answer)
- C. Episomes
- D. Conjugation
Explanation: ***Correct Option: Transduction*** - **Transduction** is the transfer of genetic material via **bacteriophages** and is the **most common mechanism** of horizontal gene transfer in *Staphylococcus aureus*. - Bacteriophages play a crucial role in disseminating **antibiotic resistance genes** in staphylococci, including genes for **methicillin resistance (mecA)**, **toxins**, and **beta-lactamase**. - Phage-mediated transfer is responsible for spreading many **virulence factors** and **resistance determinants** among staphylococcal populations. *Incorrect Option: Episomes* - **Episomes** are plasmids capable of integrating into the bacterial chromosome or existing autonomously. - While episomes can **carry resistance genes**, they are a **genetic element**, not a **mechanism of transfer**. - The question asks about the mechanism, not the vehicle carrying resistance genes. *Incorrect Option: Transformation* - **Transformation** involves uptake of **naked DNA** from the environment. - *Staphylococcus* species are **not naturally competent** for transformation under normal conditions. - This is not a significant mechanism of resistance acquisition in staphylococci. *Incorrect Option: Conjugation* - **Conjugation** requires direct cell-to-cell contact through a **conjugative pilus**. - While possible in *Staphylococcus*, it is **less common** compared to transduction. - Conjugation is more characteristic of **Gram-negative bacteria** and enterococci among Gram-positives.
Question 5: Drug of choice in methicillin-resistant Staphylococcus aureus is:
- A. Vancomycin (Correct Answer)
- B. Ampicillin
- C. Ceftriaxone
- D. Ceftazidime
Explanation: ***Vancomycin*** - **Vancomycin** is a **glycopeptide antibiotic** that kills bacteria by inhibiting peptidoglycan synthesis in the bacterial cell wall. - It is considered the **drug of choice** for serious **methicillin-resistant Staphylococcus aureus (MRSA)** infections due to its consistent activity against these resistant strains. *Ampicillin* - **Ampicillin** is a **penicillin-class antibiotic** that inhibits bacterial cell wall synthesis. - It is **ineffective against MRSA** because MRSA strains produce an **altered penicillin-binding protein (PBP2a)** that has low affinity for beta-lactam antibiotics, rendering penicillin-class drugs ineffective. *Ceftriaxone* - **Ceftriaxone** is a **third-generation cephalosporin**, which also inhibits bacterial cell wall synthesis. - Like penicillins, cephalosporins are **generally ineffective against MRSA** due to the presence of altered penicillin-binding proteins (PBP2a) in MRSA. *Ceftazidime* - **Ceftazidime** is another **third-generation cephalosporin** primarily used for its activity against **Pseudomonas aeruginosa**. - It is **not effective against MRSA**, as MRSA expresses PBP2a, rendering it resistant to most beta-lactam antibiotics, including ceftazidime.
Question 6: What is the mechanism of resistance in MRSA?
- A. PBP2a alteration (Correct Answer)
- B. Efflux pump activation
- C. Porins modification
- D. Beta-lactamase production
Explanation: ***PBP2a alteration*** - Methicillin-resistant Staphylococcus aureus (MRSA) acquires the **mecA gene**, which encodes for a modified penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for **beta-lactam antibiotics**, allowing the bacteria to synthesize its cell wall even in the presence of these drugs. *Efflux pump activation* - Efflux pumps are mechanisms used by bacteria to actively pump out various antibiotics from their cells, leading to resistance. - While efflux pumps contribute to resistance against other antibiotics, they are **not the primary mechanism** of methicillin resistance in MRSA. *Porins modification* - Porins are channels in the outer membrane of Gram-negative bacteria that allow the passage of hydrophilic molecules, including some antibiotics. - Modification of porins is a common resistance mechanism in **Gram-negative bacteria** but is not relevant to MRSA, which is Gram-positive. *Beta-lactamase production* - Beta-lactamases are enzymes that **hydrolyze the beta-lactam ring** of antibiotics like penicillin, rendering them inactive. - While many Staphylococcus aureus strains produce beta-lactamase (penicillinase) causing resistance to penicillins, MRSA's resistance to methicillin and other broader-spectrum beta-lactams is primarily due to **PBP2a alteration**, not just beta-lactamase production.
Question 7: All of the following are true about methicillin resistance in MRSA, except:
- A. Resistance is produced as a result of altered PBPs
- B. Resistance may be missed at incubation temperature of 37°C during susceptibility testing
- C. Resistance is primarily mediated/transmitted by plasmids (Correct Answer)
- D. Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics
Explanation: ***Resistance is primarily mediated/transmitted by plasmids*** - Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**. - The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**. - This is the **false statement** and hence the correct answer to this "except" question. *Resistance is produced as a result of altered PBPs* - This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs. *Resistance may be missed at incubation temperature of 37°C during susceptibility testing* - This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent. - Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance. *Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics* - This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target. - This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.
Question 8: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
- A. Carbapenems (Correct Answer)
- B. Oxyimino-cephalosporins
- C. Penicillins
- D. Cephalosporins
Explanation: ***Carbapenems*** - **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria. - The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**. *Oxyimino-cephalosporins* - ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**. - This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms. *Penicillins* - ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors. - This broadens the resistance spectrum beyond just cephalosporins to include common penicillins. *Cephalosporins* - ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**. - This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.
Question 9: All are false about tigecycline, except:-
- A. 90% pseudomonas strains are sensitive
- B. It is bactericidal drug
- C. It is a broad spectrum antimicrobial (Correct Answer)
- D. Dose reduction is required in renal failure
Explanation: ***It is a broad spectrum antimicrobial*** - **Tigecycline** is known for its wide spectrum of activity, effective against a variety of gram-positive, gram-negative, and anaerobic bacteria. - It is particularly useful in treating infections caused by **multidrug-resistant (MDR)** organisms, including MRSA and VRE. *90% pseudomonas strains are sensitive* - Tigecycline generally has **poor activity** against *Pseudomonas aeruginosa*, and its use is specifically cautioned against for such infections. - **Many *Pseudomonas* strains are intrinsically resistant** to tigecycline, making it an unreliable choice for treating these infections. *It is bactericidal drug* - Tigecycline is a **bacteriostatic** antibiotic, meaning it inhibits bacterial growth rather than directly killing bacteria. - It achieves its effect by binding to the **30S ribosomal subunit**, thereby blocking protein synthesis. *Dose reduction is required in renal failure* - **Tigecycline** is primarily eliminated via **biliary and fecal excretion**, with only a small portion excreted renally. - Therefore, **dose adjustments are generally not required** in patients with renal impairment, but caution is usually advised in severe hepatic impairment.
Question 10: Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
- A. Due to plasmid exchange with other bacteria
- B. Due to absence of cell wall making beta-lactams ineffective
- C. Due to biofilm formation protecting from antibiotics
- D. Due to rapid mutation in the 23S rRNA gene (Correct Answer)
Explanation: ***Due to rapid mutation in the 23S rRNA gene*** [1] - *Mycoplasma genitalium* develops **resistance to macrolides**, a primary treatment, through **point mutations in the 23S rRNA gene** [1]. - These mutations alter the ribosomal binding site, preventing macrolide antibiotics from inhibiting **bacterial protein synthesis** [2]. *Due to plasmid exchange with other bacteria* - *Mycoplasma genitalium* **lacks a cell wall** and generally does not engage in significant plasmid exchange, which is a common mechanism for horizontal gene transfer and resistance acquisition in many other bacteria. - While other bacteria acquire resistance through plasmids, this mechanism is **not prominent** in *Mycoplasma genitalium*. *Due to absence of cell wall making beta-lactams ineffective* - The **absence of a cell wall** inherently makes beta-lactam antibiotics ineffective against *Mycoplasma genitalium*, as **beta-lactams target cell wall synthesis**. - However, this is a **natural resistance** and does not explain its higher rate of acquired antimicrobial resistance to other classes of antibiotics, such as macrolides. *Due to biofilm formation protecting from antibiotics* - While **biofilm formation can protect bacteria** from antibiotics, it is not the primary or most notable mechanism explaining the high rate of acquired resistance in *Mycoplasma genitalium*. - The major concern for *M. genitalium* resistance lies in **specific genetic mutations** affecting relevant antibiotic targets.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free